Lalita Ramakrishnan

Lalita Ramakrishnan
Lalita Ramakrishnan at the Royal Society admissions day in London, July 2018
Born1959 (age 64–65)
Baroda, Gujarat, India
Alma materBaroda Medical College (BM)
Tufts University (PhD)
SpouseMark Troll
Parent
RelativesVenki Ramakrishnan (brother)
AwardsMember of the National Academy of Sciences (2015)
EMBO Member (2019)[1]
Scientific career
FieldsMicrobiology
Immunology
Infectious diseases[2]
InstitutionsUniversity of Cambridge
University of Washington
ThesisAbelson virus-transformed cells as models of early B lymphocyte differentiation (1990)
Websitewww.med.cam.ac.uk/ramakrishnan/ Edit this at Wikidata

Lalita Ramakrishnan FRS FMedSci (born 1959) is an Indian-born American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis.[3][4][5] As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician.[6] Her research is conducted at the MRC Laboratory of Molecular Biology (MRC LMB), where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis.[7][6] Her work has appeared in a number of journals, including Science, Nature, and Cell.[2][8][4] In 2018 and 2019 Ramakrishnan coauthored two influential papers[9] in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high.[10][11] She is married to Mark Troll, a physical chemist.[12][13][14]

  1. ^ Cite error: The named reference membo was invoked but never defined (see the help page).
  2. ^ a b Lalita Ramakrishnan publications indexed by Google Scholar Edit this at Wikidata
  3. ^ Anon (2013). "An interview with Lalita Ramakrishnan". Trends in Pharmacological Sciences. 34 (4): 197. doi:10.1016/j.tips.2013.02.005. PMID 23566316.
  4. ^ a b "Awardee Profile - Lalita Ramakrishnan | Burroughs Wellcome Fund". bwfund.org. Retrieved 24 April 2016.
  5. ^ "Principal Research Fellows". wellcome.ac.uk. Wellcome Trust. Retrieved 24 April 2016.
  6. ^ a b Sheffield, University of. "Professor Lalita Ramakrishnan - Faculty Events - Faculty of Medicine, Dentistry and Health - Faculties - The University of Sheffield". sheffield.ac.uk. Retrieved 24 April 2016.
  7. ^ P L Small; L Ramakrishnan; S Falkow (1 February 1994). "Remodeling schemes of intracellular pathogens". Science. 263 (5147): 637–639. doi:10.1126/SCIENCE.8303269. ISSN 0036-8075. PMID 8303269. Wikidata Q72761680.
  8. ^ Lalita Ramakrishnan publications indexed by the Scopus bibliographic database. (subscription required)
  9. ^ Cite error: The named reference NYT was invoked but never defined (see the help page).
  10. ^ Marcel A Behr; Paul H Edelstein; Lalita Ramakrishnan (23 August 2018). "Revisiting the timetable of tuberculosis". The BMJ. 362: k2738. doi:10.1136/BMJ.K2738. ISSN 0959-8138. PMC 6105930. PMID 30139910. Wikidata Q58716327.
  11. ^ Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (24 October 2019). "Is Mycobacterium tuberculosis infection life long?". BMJ. 367: l5770. doi:10.1136/bmj.l5770. ISSN 0959-8138. PMC 6812595. PMID 31649096.
  12. ^ "The Nobel Prize in Chemistry 2009". NobelPrize.org. Retrieved 8 February 2022.
  13. ^ Cohen, Fiona (25 November 2009). "A Nobel goes to a member of a Seattle scientific family". Seattle Post-Intelligencer. Retrieved 8 February 2022.
  14. ^ Chidan, Rajghatta (9 October 2009). "Venkatraman Ramakrishnan: Science bonds Nobel winner Venky's family". timesofindia.indiatimes.com. The Times of India. Retrieved 8 February 2022.

Developed by StudentB